Kayne Anderson Rudnick Investment Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.59M | Sell |
23,068
-1,278
| -5% | -$88.2K | ﹤0.01% | 341 |
|
|
2025
Q1 | $1.69M | Sell |
24,346
-1,427
| -6% | -$99.1K | ﹤0.01% | 353 |
|
|
2024
Q4 | $2.22M | Sell |
25,773
-894
| -3% | -$76.9K | 0.01% | 329 |
|
|
2024
Q3 | $3.18M | Sell |
26,667
-9,941
| -27% | -$1.18M | 0.01% | 296 |
|
|
2024
Q2 | $5.23M | Sell |
36,608
-7,606
| -17% | -$1.09M | 0.01% | 281 |
|
|
2024
Q1 | $5.68M | Sell |
44,214
-7,241
| -14% | -$930K | 0.01% | 282 |
|
|
2023
Q4 | $5.32M | Buy |
51,455
+3,769
| +8% | +$390K | 0.01% | 287 |
|
|
2023
Q3 | $4.34M | Sell |
47,686
-5,148
| -10% | -$468K | 0.01% | 296 |
|
|
2023
Q2 | $4.28M | Buy |
52,834
+2,506
| +5% | +$203K | 0.01% | 305 |
|
|
2023
Q1 | $4M | Buy |
50,328
+9,010
| +22% | +$717K | 0.01% | 304 |
|
|
2022
Q4 | $2.8M | Buy |
41,318
+7,474
| +22% | +$506K | 0.01% | 322 |
|
|
2022
Q3 | $1.69M | Buy |
+33,844
| New | +$1.69M | 0.01% | 331 |
|
|
2022
Q2 | – | Sell |
-90
| Closed | -$5K | – | 657 |
|
|
2022
Q1 | $5K | Buy |
+90
| New | +$5K | ﹤0.01% | 568 |
|
|
2016
Q3 | – | Sell |
-127,618
| Closed | -$3.43M | – | 338 |
|
|
2016
Q2 | $3.43M | Sell |
127,618
-2,106
| -2% | -$56.6K | 0.05% | 195 |
|
|
2016
Q1 | $3.52M | Buy |
129,724
+46,906
| +57% | +$1.27M | 0.06% | 177 |
|
|
2015
Q4 | $2.41M | Buy |
82,818
+30,460
| +58% | +$885K | 0.04% | 209 |
|
|
2015
Q3 | $1.42M | Buy |
52,358
+44,950
| +607% | +$1.22M | 0.02% | 238 |
|
|
2015
Q2 | $203K | Buy |
+7,408
| New | +$203K | ﹤0.01% | 303 |
|